Geneos Wealth Management’s abrdn Bloomberg All Commodity Strategy K-1 Free ETF BCI Stock Holding History

Geneos Wealth Management’s Portfolio BCI Stock Details BCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	45,126 +6,970	+18%	+$169K	0.02%	539
2026 Q1	$927K	Buy	38,156 +18,257	+92%	+$399K	0.02%	526
2025 Q4	$389K	Buy	19,899 +2,435	+14%	+$54.1K	0.01%	740
2025 Q3	$376K	Sell	17,464 -68,737	-80%	-$1.44M	0.01%	729
2025 Q2	$1.79M	Sell	86,201 -7,430	-8%	-$154K	0.04%	391
2025 Q1	$2.01M	Buy	93,631 +69,997	+296%	+$1.46M	0.07%	309
2024 Q4	$467K	Sell	23,634 -3,066	-11%	-$61.8K	0.02%	609
2024 Q3	$546K	Buy	+26,700	New	+$527K	0.02%	537
2022 Q2	–	Sell	-127	Closed	-$3K	–	2592
2022 Q1	$3K	Buy	+127	New	+$3.35K	﹤0.01%	2446
2019 Q1	–	Sell	-664	Closed	-$14K	–	2407
2018 Q4	$14K	Buy	+664	New	+$15.5K	﹤0.01%	1650

Other funds holding BCI

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

MGP

Metis Global Partners San Diego, California $4.41B AUM 36.75% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

AWC

Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NEPC LLC Boston, Massachusetts $5.36B AUM 7.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return

Geneos Wealth Management's BCI Position: Q2 2026 in Review

Geneos Wealth Management increased its abrdn Bloomberg All Commodity Strategy K-1 Free ETF (BCI) stake by 18% in Q2 2026, buying an estimated $169K and bringing the position to 45,126 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #539.

Geneos Wealth Management first reported a position in BCI in Q4 2018 and has held it in 10 quarters since. The position peaked at $2.01M in Q1 2025. 211 funds tracked by Wall St. Rank hold BCI as of Q2 2026.

Geneos Wealth Management held 45,126 shares of abrdn Bloomberg All Commodity Strategy K-1 Free ETF worth $1.01M as of Q2 2026.
Geneos Wealth Management bought 6,970 abrdn Bloomberg All Commodity Strategy K-1 Free ETF shares in Q2 2026, an estimated $169K.
abrdn Bloomberg All Commodity Strategy K-1 Free ETF made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #539 holding.
Geneos Wealth Management first reported a position in abrdn Bloomberg All Commodity Strategy K-1 Free ETF in Q4 2018 and has held it in 10 quarters since.
Geneos Wealth Management's abrdn Bloomberg All Commodity Strategy K-1 Free ETF position peaked at $2.01M in Q1 2025.
211 funds tracked by Wall St. Rank held abrdn Bloomberg All Commodity Strategy K-1 Free ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.